David Happel - Insider Trading & Ownership

Entity
Individual
Location
7 Hamilton Landing, Suite 100, Novato, CA
Summary
The estimated net worth of David Happel is at least $3.37M dollars as of March 28, 2024. David Happel is the President & CEO, Director of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $3.37M.
All Insider Reports
All Insider Reports

Ownership of David Happel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGMT Sagimet Biosciences Inc. President & CEO, Director $3.37M +$71.7K +2.18% Mar 26, 2024

Insider Transactions Reported by David Happel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.